Author: Admin

Developer

Harte-Hanks Inc. (HRTH) – Raising Price Target; Shifting More Attention Toward Growth

Posted on by Admin

Thursday, April 01, 2021

Harte-Hanks Inc. (HRTH)
Raising Price Target; Shifting More Attention Toward Growth

Harte-Hanks is a marketing services company that provides multichannel marketing solutions as well as consulting, data analytics, and strategic assessment. The company’s offerings focus on business-to-business, retail, finance, and automotive segments through digital, social, mobile, and print media offerings. Harte-Hanks strives to develop better customer relationships through its marketing and analytical services for clients. The majority of its revenue is derived from its marketing services in the retail, technology, and consumer brand segments.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Increased transparency. The company filed its 10K last week with segment results by quarter for 2019 and 2020. We believe that the segment data provides greater operating transparency. In this report, we provide our segment forecasts and our quarterly and full year 2021 estimates, as well as our full year 2022 estimates.

    Refining Q1 estimates.  Q1 ’21 is expected to reflect total company revenue growth, the first time since 2014, on the heals of a strong performance in its Customer Care segment. While revenue growth is not expected to be sustainable in the following 2021 quarters, it illustrates that the company is on the cusp of improved revenues and cash flow performance. Importantly, Q1 cash flow, as measured by …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Bunker Hill Mining (BHLL)(BNKR:CA) – Files 10-KT Transition Report for the Six Months Ended December 31 2020

Posted on by Admin


Bunker Hill Files 10-KT Transition Report for the Six Months Ended December 31, 2020

 

TORONTO, March 31, 2021 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (CSE: BNKR) (“Bunker Hill” or the “Company) reports that it has filed a Form 10-KT transition report for the six months ended December 31, 2020, consistent with the change in its fiscal year end as announced on February 12, 2021. The report includes the Company’s audited financial statements for the six months ended December 31, 2020, management’s discussion and analysis, and other disclosure including all material events since the change in the Company’s management team approximately one year ago.
 

Sam Ash, CEO of Bunker Hill, stated: “As we look back on our first full year of Bunker Hill under new management, we are proud of the significant milestones that we have accomplished for our investors and stakeholders, including establishing and upgrading our resource, making a meaningfully positive impact on the environment and our community, and making significant strides to re-starting the mine. We look forward to realizing our near-term catalysts, most notably publishing our PEA”.

Key achievements over the last 12 months are summarized in the table below:

NEW

MANAGEMENT

TEAM
  • Richard Williams appointed Executive Chairman in March 2020; previously Barrick’s COO
  • Sam Ash appointed President & CEO in April 2020; previously Barrick’s GM of Lumwana Copper Mine
  • Brad Barnett appointed VP Sustainability in April 2020; previously Barrick’s Head of Closure & Rehab
  • David Wiens appointed CFO & Corporate Secretary on January 12, 2021; previously SSR Mining
ESG

DRIVEN

VISION
  • Water management program launched in September 2020; commissioned pre-treatment plant designed to significantly improve quality of Mine discharge water; immediate results
  • Engagement with community and local stakeholders
  • Pam Saxton appointed Independent Director in October 2020; Chair of Audit Committee
  • Cassandra Joseph appointed Independent Director in November 2020; Chair of Governance Committee
ADVANCED

POTENTIAL

MINE RESTART
  • Renegotiated Lease and Option Agreement in November 2020, lowering cash purchase price to $3.4M
  • Repaired several thousand feet of Russell Tunnel, providing early access to UTZ Zone, Quill and Newgard Zones, with plans to extend further access
  • Launched PEA assessing rapid production restart; results expected early Q2-2021
EXPLORATION

SUCCESS
  • Digitized 95 years of historical data to develop proprietary geological model and prioritize targets
  • Achieved maiden mineral resource estimate announced in September 2020
  • Announced upgraded mineral resource estimate in March 2021
  • Confirmed high grade silver mineralization results in several areas through drilling and chip sampling

For further information please see the Company’s Form 10-KT filed on SEDAR at www.sedar.com and EDGAR www.sec.gov under the Company’s profile.

UPCOMING EVENTS

Adelaide Capital Idaho Conference
April 8, 2021 @ 12:00pm ET – 4:00pm ET
Join Us: REGISTER NOW

World Gold Forum
April 13-15, 2021
https://www.worldgoldforum.com/

HC Wainwright Mining Conference
April 19-20, 2021
Join Us: REGISTER NOW

121 Mining Investment Americas
April 27-29, 2021
https://www.weare121.com/121mininginvestment-new-york/

QUALIFIED PERSON

Mr. Scott E. Wilson, CPG, President of Resource Development Associates Inc. and a consultant to the Company, is an independent qualified person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects and is acting as the qualified person for the Company. He has reviewed and approved the technical information summarized in this news release.

ABOUT BUNKER HILL MINING CORP.

Under new Idaho-based leadership, Bunker Hill Mining Corp. intends to sustainably restart and develop the Bunker Hill Mine as the first step in consolidating a portfolio of North American precious-metal assets with a focus on silver. Information about the Company is available on its website, www.bunkerhillmining.com , or under the Company’s profile on SEDAR at www.sedar.com and on EDGAR at www.sec.gov .

For additional information contact:

Sam Ash, President and Chief Executive Officer

+1 208 786 6999

[email protected]

CAUTIONARY STATEMENTS

Certain statements in this news release are forward-looking and involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, as well as within the meaning of the phrase ‘forward-looking information’ in the Canadian Securities Administrators’ National Instrument 51-102 – Continuous Disclosure Obligations. Forward-looking statements are not comprised of historical facts. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by terminology such as “may”, “will”, “could”, “should”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “projects”, “predict”, “potential”, “continue” or other similar expressions concerning matters that are not historical facts.

Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The key risks and uncertainties include, but are not limited to: local and global political and economic conditions; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy, government ownership requirements, changes in environmental, tax and other laws or regulations and the interpretation thereof; developments with respect to the coronavirus disease 2019 (“COVID-19”) pandemic, including the duration, severity and scope of the pandemic and potential impacts on mining operations; and other risk factors detailed from time to time in the Company’s reports filed on SEDAR and EDGAR.

Forward-looking information and statements in this news release include statements concerning, among other things: the Company’s plans to extend further access to the UTZ Zone, Quill and Newgard Zones; the timing for publishing the PEA aimed at assessing the mine’s rapid restart potential; and the Company’s intentions regarding its objectives, goals or future plans and statements. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to: the ability to predict and counteract the effects of COVID-19 on the business of the Company, including but not limited to the effects of COVID-19 on the price of commodities, capital market conditions, restriction on labor and international travel and supply chains; failure to identify mineral resources; failure to convert estimated mineral resources to reserves; the inability to complete a feasibility study which recommends a production decision; the preliminary nature of metallurgical test results; delays in obtaining or failures to obtain required governmental, environmental or other project approvals; political risks; changes in equity markets; uncertainties relating to the availability and costs of financing needed in the future; the inability of the Company to budget and manage its liquidity in light of the failure to obtain additional financing, including the ability of the Company to complete the payments pursuant to the terms of the agreement to acquire the Bunker Hill Mine Complex; inflation; changes in exchange rates; fluctuations in commodity prices; delays in the development of projects; capital, operating and reclamation costs varying significantly from estimates and the other risks involved in the mineral exploration and development industry; and those risks set out in the Company’s public documents filed on SEDAR and EDGAR. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

Source: Bunker Hill Mining

Onconova Therapeutics (ONTX) – Announces Enrollment In Second Cohort Of Phase 1 Study With ON 123300 In China

Posted on by Admin


Onconova Therapeutics Announces Enrollment In Second Cohort Of Phase 1 Study With ON 123300 In China

 

Corporate Partner HanX Biopharmaceuticals enrolled third patient in 80 mg group

NEWTOWN, Pa., April 01, 2021 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announces that its corporate partner HanX Biopharmaceuticals has enrolled three patients in the second dosing cohort of its Phase 1 study with ON 123300 in HR+ HER2- metastatic breast cancer and other advanced relapsed/refractory cancers in China.

The HanX trial has enrolled six patients to date in two cohorts and may continue to enroll patients with advanced relapsed/refractory cancer at increasing doses with three to six patients per dose until the recommended Phase 2 dose is identified.   To date, patients have been dosed at the 40 mg and 80 mg dosage levels. HanX recently opened a third site, in Shanghai, for the conduct of the study.

“We are encouraged that the HanX Phase 1 study is proceeding as planned, and look forward to the identification of a recommended Phase 2 dose to move into later-stage trials. The third cohort in this trial with 120 mg of ON 123300 is expected to begin enrollment next; depending on the incidence of dose limiting toxicities, if any, at the 80 mg cohort,” said Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova Therapeutics. “The HanX study trial design calls for dosing on days 1-21 of each 28-day cycle, compared with our planned Phase 1 study in the U.S. that will assess the safety, tolerability and pharmacokinetics of ON 123300 administered orally as monotherapy at increasing doses starting at 40 mg daily for continuous 28-day cycles. We are preparing to begin our U.S. study in the second quarter of 2021.”

“ON 123300 is a multi-kinase inhibitor in addition to targeting CDK 4/6, which we believe presents an innovative approach to treating advanced cancers including HR+ HER2- metastatic breast cancer that is, or has become, resistant to commercial CDK 4/6 inhibitors. Beyond metastatic breast cancer, we believe ON 123300 may present an innovative approach to treating other cancers including mantle cell lymphoma, multiple myeloma, advanced colorectal cancer, hepatocellular carcinoma and inoperable glioblastoma,” concluded Dr. Fruchtman.

In December 2017, Onconova entered into an agreement with HanX Biopharmaceuticals for the development, registration, and commercialization of ON 123300 in Greater China. The agreement included a licensing fee, future potential milestone payments, and royalties on sales. Onconova retains rights to ON 123300 in the rest of the world outside of Greater China.

About Onconova Therapeutics, Inc.

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.

Onconova’s novel, proprietary multi-kinase inhibitor ON 123300 is planned to begin a dose-escalation and expansion Phase 1 trial in the U.S. in 2Q21, and a dose-escalation and expansion Phase 1 trial is currently underway in China.

Onconova’s product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. In addition, Onconova continues to conduct preclinical work investigating rigosertib in COVID-19.

For more information, please visit www.onconova.com.

Forward-Looking Statements

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, and involve risks and uncertainties. These statements relate to Onconova’s expectations regarding the registered direct offering, its patents and clinical development plans including patient enrollment timelines and indications for its product candidates. Onconova has attempted to identify forward-looking statements by terminology including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” “approximately” or other words that convey uncertainty of future events or outcomes. Although Onconova believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including the success and timing of Onconova’s clinical trials and regulatory agency and institutional review board approvals of protocols, Onconova’s ability to continue as a going concern, the need for additional financing, Onconova’s collaborations, market conditions and those discussed under the heading “Risk Factors” in Onconova’s most recent Annual Report on Form 10-K and quarterly reports on Form 10-Q. Any forward-looking statements contained in this release speak only as of its date. Onconova undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

Company Contact:
Avi Oler
Onconova Therapeutics, Inc.
267-759-3680
[email protected]
https://www.onconova.com/contact/

Investor Contact:
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
[email protected]

Source: Onconova Therapeutics

Golden Predator Mining (NTGSF)(GPY:CA) – Submits Brewery Creek License Renewal Applications

Posted on by Admin


Golden Predator Submits Brewery Creek License Renewal Applications

 

Vancouver, BC, April 1, 2021:
Golden Predator Mining Corp. (TSX.V:GPY, OTCQX:NTGSF) (the “Company” or “Golden Predator”) advises the Company has submitted its Water Use License
(WUL) and Quartz Mining License (QML) renewal applications for its 100%-owned Brewery Creek mine project
located approximately 55 km by paved and gravel road from Dawson City, Yukon.
The Company looks forward to working with Tr’ondëk Hwëch’in, the Yukon
Department of Energy, Mines and Resources and the Yukon Water Board to advance
the renewal applications.  

The Brewery Creek Mine is a brownfields heap leach gold mine that was operated by Viceroy Minerals Corporation from 1996 to 2002. Important infrastructure remains in place allowing for a timely restart schedule.

Brewery Creek currently holds valid Quartz Mining and Water Use Licenses, which expire December 31, 2021. The Company has submitted renewal applications on existing terms and conditions for 10-year extensions to the Quartz Mining License (QML) Water Use License (WUL). Golden Predator is currently working on a document to meet Yukon Environmental Socioeconomic Assessment Act (YESAA) requirements and expects to submit the project plan in early Q3 2021.

Brewery Creek Mine Work Plan

A Feasibility Study (FS) is being conducted by Kappes Cassiday & Associates of Reno, Nevada which will include a multi-year mine plan for the advancement of the Brewery Creek project.   The FS will include an inventory of the mineralized material remaining on the heap and mine planning (completed by Tetra Tech Inc of Golden, Colorado) for the resumption of the mining of material from leachable resources contained within the licensed area and reported in the Company’s Mineral Resource Estimate.  The FS will include all the key parameters involved in reconstructing or adding necessary infrastructure including a crushing facility, the Adsorption-Desorption-Recovery (“ADR”) plant, mine schedule, operating and capital cost estimates, and economic cash flow model sufficiently detailed to move directly into procurement, development and construction if economically warranted. Any production decisions would be dependent on the outcome of a study demonstrating positive technical and economic viability.

Golden Predator Mining Corp – Viva Gold  Corp. (TSX.V: VAU; OTCQB: VAUCF) (“Viva Gold“)

The Company previously announced (March 3, 2021)  it has entered into a definitive arrangement agreement whereby Golden Predator will acquire all of the outstanding securities of Viva Gold by way of a plan of arrangement under the Business Corporations Act (British Columbia). The proposed Arrangement brings together proven mine building expertise, jurisdictional diversification and two advanced stage gold development projects as the two company’s merge their Nevada and Yukon assets and management to position the company as an emerging junior gold producer.

The technical content of this news release has been reviewed and approved by Michael Maslowski CPG, a Qualified Person as defined by National Instrument 43-101 and a consultant to the Company.

About Golden Predator Mining Corp.

Golden Predator is advancing the past-producing Brewery Creek Mine towards a timely resumption of mining activities in Canada’s Yukon. The project has established resources grading over 1.0 g/t Gold and both a technical report and Bankable Feasibility Study underway to define the economics of a restart of heap leach operations at the Brewery Creek Mine. The 180 km2 brownfield property is located 55 km by road from Dawson City, Yukon and operates under a Socio-Economic Accord with the Tr’ondëk Hwëch’in First Nation.  The Company also holds the Marg Project, with a 43-101 compliant resource, the Gold Dome Project and Grew Creek Project. For additional information on Golden Predator and the Brewery Creek Mine, please visit our website: www.goldenpredator.com.

For additional information:
Janet Lee-Sheriff
Chief Executive Officer
(604) 260-8435
[email protected]

www.goldenpredator.com

Neither TSX
Venture Exchange nor its Regulation Services Provider (as that term is defined
in policies of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release. No stock exchange, securities commission
or other regulatory authority has approved or disapproved the information
contained herein. This press release contains forward-looking information that
involve various risks and uncertainties regarding future events. Such
forward-looking information can include without limitation statements based on
current expectations that the Brewery Creek will advance to an early production
decision, or the extent of any additional mineral resource that could result
from incorporating 2019 exploration drilling.  Actual results and future
events could differ materially from those anticipated in such information. These
and all subsequent written and oral forward-looking information are based on
estimates and opinions of management on the dates they are made and are
expressly qualified in their entirety by this notice. Except as required by
law, the Company assumes no obligation to update forward-looking information
should circumstances or management’s estimates or opinions change.

Was There Ever a Market Crash on Good Friday?

Posted on by Admin

 


The Real Reason the NYSE is Closed Good Friday

 

Three times a year, the NYSE’s holiday schedule differs from the U.S. Federal Government. Federal office closings usually dictate bank holidays as well. This happens on Columbus Day and Veterans Day; on these days, banks and the Federal Government are closed, the stock exchanges are open. Only on Good Friday is the market closed as Federal workers and bank employees have a regular workday.  Interestingly, the Friday before Easter is the only non-federal holiday among the exchange’s nine annual holidays. Traders, stock market employees, and others associated with transacting for U.S. equity markets can keep their work computers off, receive USPS mail, run to the bank, and even chat by phone with the IRS.

Why This One Particular Day?

Wall Street is full of superstitions, sayings, and stories with varying degrees of truthiness. The granddaddy of exchanges, the New York Stock Exchange, has been closed the Friday before Easter for over 150 years. There have been three exceptions (1898, 1906, and 1907), and during these years it stayed open that Friday. There is an often-heard tale that has circulated, referring to this day as “Black Friday.” As this fake news story goes, the NYSE had once opened its doors on a Good Friday, which occurs on the holiest week of the year for Christians, and the stock market had a terrible crash. This “bad karma” caused those governing the NYSE to vow to never again allow trading on the exchange on Good Friday.

There is no record of anything that would fit the above narrative. Plus, it begs the question, “why isn’t the market closed for superstitious reasons on other days of horrific selloffs?” Maybe March 23rd would be a wise day for those running the exchanges to consider guarding against the first week of Spring selloff in 2020.

Why there is no record? Because it never happened. Apparently, the story isn’t even Snopes-worthy because the only entries related to Good Friday or Black Friday respond to questions about Thanksgiving and resurrection, not market selloffs.

 

 

But I did find a story from what I deem to be a credible source or at least a wise codger that is believable on this question.  Art Cashin, the recognizable NYSE floor trader for UBS, slapped down this myth in his daily emailed newsletter back in 2011. In short, he wrote, “it never happened.”

Text From Art Cashin’s 2011 UBS Newsletter

“In the over five decades that I’ve been in Wall Street, each
Easter season sees the re-blooming of an old — and erroneous — myth.

“That myth contends that the NYSE opened on a Good Friday
and the terrible Black Friday crash occurred. Thus, chastened and shaken, the
Governors vowed never to open on a Good Friday again. It never happened.

“Thanks to the nice folks in the NYSE archives we were able
to establish a few facts. Records clearly show the NYSE closed on Good Friday
as far back as 1864. Before 1864 records on the subject are a bit harder to
find but there is high likelihood that the Exchange closed on Good Friday all
the way back to 1793. (It was founded on May 17th, 1792 so Good Friday would
have already passed that year.)

“There was a famous and terrible Black Friday crash in Wall
Street but it was primarily in the gold market. It came about when the ‘corner’
on gold that
Jay Gould and Jim Fisk had constructed (with
some help from President Grant’s brother-in-law), collapsed. That occurred on
September 24th, 1869, a little late in the year for Good Friday. You will also
note from the search of the records that the NYSE was closing on Good Friday at
least five years earlier and probably, much, much longer.

“Lastly, for some unexplained reason, the NYSE stayed open
on three Good Fridays. On April 8, 1898, the Dow closed down a half point.
That’s hardly a crash. On the other two, April 13th, 1906 (a Friday the 13th)
and March 29th, 1907, the Dow actually rose.”

“I hope that puts the myth to bed.”

Two Last Points

  • Of the three years the market stayed open on Good Friday, two closed higher than they opened, and one (1898) closed lower.
  • If you’re off today or missing the excitement of trading, enjoy your long weekend, the market will be there for you on Monday.

Paul Hoffman

Managing Director, Channelchek


Suggested Reading:

Long Term Retirement Money and Fledgling Companies

How Good are Experts at Predicting the Market?



An Opportunity to Ditch Chemotherapy and Still Treat Cancer

PSCs Can Function Like Embryonic Stem Cells

 

Sources:

Stock Market Legend Art Cashin

NYSE Holidays and Trading Hours

NYSE Historical Data

Photo: Art Cashin, NYSE

Stay up to date. Follow us:

           


Stay up to date. Follow us:

QuickChek – April 1, 2021

Posted on by Admin



Golden Predator Submits Brewery Creek License Renewal Applications

Golden Predator Mining announced that the Company has submitted its Water Use License and Quartz Mining License renewal applications for its 100%-owned Brewery Creek mine project

Research, News & Market Data on Golden Predator Mining

Watch recent presentation from NobleCon17



Bunker Hill Files 10-KT Transition Report for the Six Months Ended December 31, 2020

Bunker Hill Mining announced that it has filed a Form 10-KT transition report for the six months ended December 31, 2020, consistent with the change in its fiscal year end as announced on February 12, 2021

News & Market Data on Bunker Hill Mining



Onconova Therapeutics Announces Enrollment In Second Cohort Of Phase 1 Study With ON 123300 In China

Bunker Hill Mining announced that its corporate partner HanX Biopharmaceuticals has enrolled three patients in the second dosing cohort of its Phase 1 study with ON 123300 in China

Research, News & Market Data on Bunker Hill Mining

Watch recent presentation from NobleCon17

Stay up to date. Follow us:

Release – Golden Predator Mining (NTGSF)(GPY:CA) – Submits Brewery Creek License Renewal Applications

Posted on by Admin


Golden Predator Submits Brewery Creek License Renewal Applications

 

Vancouver, BC, April 1, 2021:
Golden Predator Mining Corp. (TSX.V:GPY, OTCQX:NTGSF) (the “Company” or “Golden Predator”) advises the Company has submitted its Water Use License
(WUL) and Quartz Mining License (QML) renewal applications for its 100%-owned Brewery Creek mine project
located approximately 55 km by paved and gravel road from Dawson City, Yukon.
The Company looks forward to working with Tr’ondëk Hwëch’in, the Yukon
Department of Energy, Mines and Resources and the Yukon Water Board to advance
the renewal applications.  

The Brewery Creek Mine is a brownfields heap leach gold mine that was operated by Viceroy Minerals Corporation from 1996 to 2002. Important infrastructure remains in place allowing for a timely restart schedule.

Brewery Creek currently holds valid Quartz Mining and Water Use Licenses, which expire December 31, 2021. The Company has submitted renewal applications on existing terms and conditions for 10-year extensions to the Quartz Mining License (QML) Water Use License (WUL). Golden Predator is currently working on a document to meet Yukon Environmental Socioeconomic Assessment Act (YESAA) requirements and expects to submit the project plan in early Q3 2021.

Brewery Creek Mine Work Plan

A Feasibility Study (FS) is being conducted by Kappes Cassiday & Associates of Reno, Nevada which will include a multi-year mine plan for the advancement of the Brewery Creek project.   The FS will include an inventory of the mineralized material remaining on the heap and mine planning (completed by Tetra Tech Inc of Golden, Colorado) for the resumption of the mining of material from leachable resources contained within the licensed area and reported in the Company’s Mineral Resource Estimate.  The FS will include all the key parameters involved in reconstructing or adding necessary infrastructure including a crushing facility, the Adsorption-Desorption-Recovery (“ADR”) plant, mine schedule, operating and capital cost estimates, and economic cash flow model sufficiently detailed to move directly into procurement, development and construction if economically warranted. Any production decisions would be dependent on the outcome of a study demonstrating positive technical and economic viability.

Golden Predator Mining Corp – Viva Gold  Corp. (TSX.V: VAU; OTCQB: VAUCF) (“Viva Gold“)

The Company previously announced (March 3, 2021)  it has entered into a definitive arrangement agreement whereby Golden Predator will acquire all of the outstanding securities of Viva Gold by way of a plan of arrangement under the Business Corporations Act (British Columbia). The proposed Arrangement brings together proven mine building expertise, jurisdictional diversification and two advanced stage gold development projects as the two company’s merge their Nevada and Yukon assets and management to position the company as an emerging junior gold producer.

The technical content of this news release has been reviewed and approved by Michael Maslowski CPG, a Qualified Person as defined by National Instrument 43-101 and a consultant to the Company.

About Golden Predator Mining Corp.

Golden Predator is advancing the past-producing Brewery Creek Mine towards a timely resumption of mining activities in Canada’s Yukon. The project has established resources grading over 1.0 g/t Gold and both a technical report and Bankable Feasibility Study underway to define the economics of a restart of heap leach operations at the Brewery Creek Mine. The 180 km2 brownfield property is located 55 km by road from Dawson City, Yukon and operates under a Socio-Economic Accord with the Tr’ondëk Hwëch’in First Nation.  The Company also holds the Marg Project, with a 43-101 compliant resource, the Gold Dome Project and Grew Creek Project. For additional information on Golden Predator and the Brewery Creek Mine, please visit our website: www.goldenpredator.com.

For additional information:
Janet Lee-Sheriff
Chief Executive Officer
(604) 260-8435
[email protected]

www.goldenpredator.com

Neither TSX
Venture Exchange nor its Regulation Services Provider (as that term is defined
in policies of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release. No stock exchange, securities commission
or other regulatory authority has approved or disapproved the information
contained herein. This press release contains forward-looking information that
involve various risks and uncertainties regarding future events. Such
forward-looking information can include without limitation statements based on
current expectations that the Brewery Creek will advance to an early production
decision, or the extent of any additional mineral resource that could result
from incorporating 2019 exploration drilling.  Actual results and future
events could differ materially from those anticipated in such information. These
and all subsequent written and oral forward-looking information are based on
estimates and opinions of management on the dates they are made and are
expressly qualified in their entirety by this notice. Except as required by
law, the Company assumes no obligation to update forward-looking information
should circumstances or management’s estimates or opinions change.

Differences Between Value and Growth

Posted on by Admin

 


Takeaways from the Ups and Downs of March

 

March came to an end, and many wounds from a rough year that followed a big fall of the various stock indices March 2020 have healed beyond the expectations held by most at this time last year. Focusing on last month (March 2021), the Nasdaq and the Russell 2000 (Small Caps) were up modestly, while the S&P 500 and the Dow Jones achieved outsized gains. One big takeaway from March 2020 is optimism among investors who feel they’re beginning to see the light at the end of the tunnel toward normalcy.

Reasons for the optimism are abundant, vaccinations are ramping up globally, travel is escalating toward more normal levels, and the latest release from the U.S. Department of Labor indicates that jobless claims have decreased to a 12-month low. It doesn’t require rose-colored-glasses to see where the overall economy has been headed with this cocktail of good news nor why the markets have been a leading positive indicator for the past year. Big money managers, as well as small investors, have been rotating out of the high-flyer tech stocks of last year and rebalancing their portfolios in anticipation of a roaring recovery.

 

Data as of March 31, 2021, 2 pm EDT

The back-to-normal expectations echoed among key opinion leaders, experts, and analysts within the finance community seem to be understood by those that actually put money to work in the stock market. Rebalancing of portfolios can be surmised from the graph above as industrial stocks lead (INDU) and the tech-heavy Nasdaq 100 (CCMP) has come to a crawl.  The numbers don’t lie, and, in this case, it is clear where the money managers are allocating. Value stocks have a reputation of supporting a strong and consistent portfolio, while growth is a riskier and more volatile option, but can reward owners willing to hold higher volatility.

During the past year, investors had been pouring their resources into growth portfolios as part of a global chain of events that aroused the need for technology, software, and various disruptive innovations. However, with the worldwide vaccine rollout and improvements in the economic outlook, portfolios are retreating some (mostly) to value. Let’s look at a brief breakdown of the Value, vs. Growth, vs. Large Cap during the first quarter of 2021.

 

Data as of March 31, 2021, 2 pm EDT

The rebalancing from growth to value started to reach a peak early in March as seen in the graph above. One thing that stands out from the current perception is that the small cap value stocks have outperformed large cap growth and large cap value. Both large and small cap value baskets have been enjoying solid performance above overall growth stocks since January 1.

Santiago Diaz

Associate Writer – Channelchek

More To Discover:

What Will the Stock Market do in the Spring?

What Stocks do You Buy When the Dollar Goes Down?



Managing Investment Portfolio Risk

IRA Investments and Small Cap Stocks

Sources:

U.S. Department of Labor

Koyfin.com

U.S. Transportation Security Administration

 

 

Stay up to date. Follow us:

           


Stay up to date. Follow us:

Release – Onconova Therapeutics (ONTX) – Announces Enrollment In Second Cohort Of Phase 1 Study With ON 123300 In China

Posted on by Admin


Onconova Therapeutics Announces Enrollment In Second Cohort Of Phase 1 Study With ON 123300 In China

 

Corporate Partner HanX Biopharmaceuticals enrolled third patient in 80 mg group

NEWTOWN, Pa., April 01, 2021 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announces that its corporate partner HanX Biopharmaceuticals has enrolled three patients in the second dosing cohort of its Phase 1 study with ON 123300 in HR+ HER2- metastatic breast cancer and other advanced relapsed/refractory cancers in China.

The HanX trial has enrolled six patients to date in two cohorts and may continue to enroll patients with advanced relapsed/refractory cancer at increasing doses with three to six patients per dose until the recommended Phase 2 dose is identified.   To date, patients have been dosed at the 40 mg and 80 mg dosage levels. HanX recently opened a third site, in Shanghai, for the conduct of the study.

“We are encouraged that the HanX Phase 1 study is proceeding as planned, and look forward to the identification of a recommended Phase 2 dose to move into later-stage trials. The third cohort in this trial with 120 mg of ON 123300 is expected to begin enrollment next; depending on the incidence of dose limiting toxicities, if any, at the 80 mg cohort,” said Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova Therapeutics. “The HanX study trial design calls for dosing on days 1-21 of each 28-day cycle, compared with our planned Phase 1 study in the U.S. that will assess the safety, tolerability and pharmacokinetics of ON 123300 administered orally as monotherapy at increasing doses starting at 40 mg daily for continuous 28-day cycles. We are preparing to begin our U.S. study in the second quarter of 2021.”

“ON 123300 is a multi-kinase inhibitor in addition to targeting CDK 4/6, which we believe presents an innovative approach to treating advanced cancers including HR+ HER2- metastatic breast cancer that is, or has become, resistant to commercial CDK 4/6 inhibitors. Beyond metastatic breast cancer, we believe ON 123300 may present an innovative approach to treating other cancers including mantle cell lymphoma, multiple myeloma, advanced colorectal cancer, hepatocellular carcinoma and inoperable glioblastoma,” concluded Dr. Fruchtman.

In December 2017, Onconova entered into an agreement with HanX Biopharmaceuticals for the development, registration, and commercialization of ON 123300 in Greater China. The agreement included a licensing fee, future potential milestone payments, and royalties on sales. Onconova retains rights to ON 123300 in the rest of the world outside of Greater China.

About Onconova Therapeutics, Inc.

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.

Onconova’s novel, proprietary multi-kinase inhibitor ON 123300 is planned to begin a dose-escalation and expansion Phase 1 trial in the U.S. in 2Q21, and a dose-escalation and expansion Phase 1 trial is currently underway in China.

Onconova’s product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. In addition, Onconova continues to conduct preclinical work investigating rigosertib in COVID-19.

For more information, please visit www.onconova.com.

Forward-Looking Statements

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, and involve risks and uncertainties. These statements relate to Onconova’s expectations regarding the registered direct offering, its patents and clinical development plans including patient enrollment timelines and indications for its product candidates. Onconova has attempted to identify forward-looking statements by terminology including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” “approximately” or other words that convey uncertainty of future events or outcomes. Although Onconova believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including the success and timing of Onconova’s clinical trials and regulatory agency and institutional review board approvals of protocols, Onconova’s ability to continue as a going concern, the need for additional financing, Onconova’s collaborations, market conditions and those discussed under the heading “Risk Factors” in Onconova’s most recent Annual Report on Form 10-K and quarterly reports on Form 10-Q. Any forward-looking statements contained in this release speak only as of its date. Onconova undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

Company Contact:
Avi Oler
Onconova Therapeutics, Inc.
267-759-3680
[email protected]
https://www.onconova.com/contact/

Investor Contact:
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
[email protected]

Source: Onconova Therapeutics

Release – Bunker Hill Mining (BHLL)(BNKR:CA) – Files 10-KT Transition Report for the Six Months Ended December 31 2020

Posted on by Admin


Bunker Hill Files 10-KT Transition Report for the Six Months Ended December 31, 2020

 

TORONTO, March 31, 2021 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (CSE: BNKR) (“Bunker Hill” or the “Company) reports that it has filed a Form 10-KT transition report for the six months ended December 31, 2020, consistent with the change in its fiscal year end as announced on February 12, 2021. The report includes the Company’s audited financial statements for the six months ended December 31, 2020, management’s discussion and analysis, and other disclosure including all material events since the change in the Company’s management team approximately one year ago.
 

Sam Ash, CEO of Bunker Hill, stated: “As we look back on our first full year of Bunker Hill under new management, we are proud of the significant milestones that we have accomplished for our investors and stakeholders, including establishing and upgrading our resource, making a meaningfully positive impact on the environment and our community, and making significant strides to re-starting the mine. We look forward to realizing our near-term catalysts, most notably publishing our PEA”.

Key achievements over the last 12 months are summarized in the table below:

NEW

MANAGEMENT

TEAM
  • Richard Williams appointed Executive Chairman in March 2020; previously Barrick’s COO
  • Sam Ash appointed President & CEO in April 2020; previously Barrick’s GM of Lumwana Copper Mine
  • Brad Barnett appointed VP Sustainability in April 2020; previously Barrick’s Head of Closure & Rehab
  • David Wiens appointed CFO & Corporate Secretary on January 12, 2021; previously SSR Mining
ESG

DRIVEN

VISION
  • Water management program launched in September 2020; commissioned pre-treatment plant designed to significantly improve quality of Mine discharge water; immediate results
  • Engagement with community and local stakeholders
  • Pam Saxton appointed Independent Director in October 2020; Chair of Audit Committee
  • Cassandra Joseph appointed Independent Director in November 2020; Chair of Governance Committee
ADVANCED

POTENTIAL

MINE RESTART
  • Renegotiated Lease and Option Agreement in November 2020, lowering cash purchase price to $3.4M
  • Repaired several thousand feet of Russell Tunnel, providing early access to UTZ Zone, Quill and Newgard Zones, with plans to extend further access
  • Launched PEA assessing rapid production restart; results expected early Q2-2021
EXPLORATION

SUCCESS
  • Digitized 95 years of historical data to develop proprietary geological model and prioritize targets
  • Achieved maiden mineral resource estimate announced in September 2020
  • Announced upgraded mineral resource estimate in March 2021
  • Confirmed high grade silver mineralization results in several areas through drilling and chip sampling

For further information please see the Company’s Form 10-KT filed on SEDAR at www.sedar.com and EDGAR www.sec.gov under the Company’s profile.

UPCOMING EVENTS

Adelaide Capital Idaho Conference
April 8, 2021 @ 12:00pm ET – 4:00pm ET
Join Us: REGISTER NOW

World Gold Forum
April 13-15, 2021
https://www.worldgoldforum.com/

HC Wainwright Mining Conference
April 19-20, 2021
Join Us: REGISTER NOW

121 Mining Investment Americas
April 27-29, 2021
https://www.weare121.com/121mininginvestment-new-york/

QUALIFIED PERSON

Mr. Scott E. Wilson, CPG, President of Resource Development Associates Inc. and a consultant to the Company, is an independent qualified person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects and is acting as the qualified person for the Company. He has reviewed and approved the technical information summarized in this news release.

ABOUT BUNKER HILL MINING CORP.

Under new Idaho-based leadership, Bunker Hill Mining Corp. intends to sustainably restart and develop the Bunker Hill Mine as the first step in consolidating a portfolio of North American precious-metal assets with a focus on silver. Information about the Company is available on its website, www.bunkerhillmining.com , or under the Company’s profile on SEDAR at www.sedar.com and on EDGAR at www.sec.gov .

For additional information contact:

Sam Ash, President and Chief Executive Officer

+1 208 786 6999

[email protected]

CAUTIONARY STATEMENTS

Certain statements in this news release are forward-looking and involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, as well as within the meaning of the phrase ‘forward-looking information’ in the Canadian Securities Administrators’ National Instrument 51-102 – Continuous Disclosure Obligations. Forward-looking statements are not comprised of historical facts. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by terminology such as “may”, “will”, “could”, “should”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “projects”, “predict”, “potential”, “continue” or other similar expressions concerning matters that are not historical facts.

Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The key risks and uncertainties include, but are not limited to: local and global political and economic conditions; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy, government ownership requirements, changes in environmental, tax and other laws or regulations and the interpretation thereof; developments with respect to the coronavirus disease 2019 (“COVID-19”) pandemic, including the duration, severity and scope of the pandemic and potential impacts on mining operations; and other risk factors detailed from time to time in the Company’s reports filed on SEDAR and EDGAR.

Forward-looking information and statements in this news release include statements concerning, among other things: the Company’s plans to extend further access to the UTZ Zone, Quill and Newgard Zones; the timing for publishing the PEA aimed at assessing the mine’s rapid restart potential; and the Company’s intentions regarding its objectives, goals or future plans and statements. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to: the ability to predict and counteract the effects of COVID-19 on the business of the Company, including but not limited to the effects of COVID-19 on the price of commodities, capital market conditions, restriction on labor and international travel and supply chains; failure to identify mineral resources; failure to convert estimated mineral resources to reserves; the inability to complete a feasibility study which recommends a production decision; the preliminary nature of metallurgical test results; delays in obtaining or failures to obtain required governmental, environmental or other project approvals; political risks; changes in equity markets; uncertainties relating to the availability and costs of financing needed in the future; the inability of the Company to budget and manage its liquidity in light of the failure to obtain additional financing, including the ability of the Company to complete the payments pursuant to the terms of the agreement to acquire the Bunker Hill Mine Complex; inflation; changes in exchange rates; fluctuations in commodity prices; delays in the development of projects; capital, operating and reclamation costs varying significantly from estimates and the other risks involved in the mineral exploration and development industry; and those risks set out in the Company’s public documents filed on SEDAR and EDGAR. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

Source: Bunker Hill Mining

Harte-Hanks Inc. (HRTH) – Raising Price Target Shifting More Attention Toward Growth

Posted on by Admin

Thursday, April 01, 2021

Harte-Hanks Inc. (HRTH)
Raising Price Target; Shifting More Attention Toward Growth

Harte-Hanks is a marketing services company that provides multichannel marketing solutions as well as consulting, data analytics, and strategic assessment. The company’s offerings focus on business-to-business, retail, finance, and automotive segments through digital, social, mobile, and print media offerings. Harte-Hanks strives to develop better customer relationships through its marketing and analytical services for clients. The majority of its revenue is derived from its marketing services in the retail, technology, and consumer brand segments.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Increased transparency. The company filed its 10K last week with segment results by quarter for 2019 and 2020. We believe that the segment data provides greater operating transparency. In this report, we provide our segment forecasts and our quarterly and full year 2021 estimates, as well as our full year 2022 estimates.

    Refining Q1 estimates.  Q1 ’21 is expected to reflect total company revenue growth, the first time since 2014, on the heals of a strong performance in its Customer Care segment. While revenue growth is not expected to be sustainable in the following 2021 quarters, it illustrates that the company is on the cusp of improved revenues and cash flow performance. Importantly, Q1 cash flow, as measured by …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Pyxis Tankers Inc. (PXS) – Refinancing Done. Shifting to Growth

Posted on by Admin

Wednesday, March 31, 2021

Pyxis Tankers Inc. (PXS)
Refinancing Done. Shifting to Growth.

Pyxis Tankers Inc is a United States-based international maritime transportation company which focuses on the product tanker sector. It owns a fleet which comprises of double hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Pyxis Epsilon, Pyxis Theta, Pyxis Malou, Pyxis Delta, Northsea Alpha, and Northsea Beta. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Refinancing completed with positive impact on interest costs. A term loan of $17 million on the Epsilon from an existing lender and cash of $7.5 million refinanced existing debt. The new loan is priced at Libor plus 335 basis points and quarterly amortization is $0.3 million with a balloon payment of ~$11 million in five years. Borrowing costs should drop by more than 200 basis points and no secured debt matures over the next two years.

    Well-timed equity offering materially improved public market float.  A private equity offering generated net proceeds of $23.1 million last month. Combined with preferred stock conversions, the public market float expanded to more than 50% …



This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Grindrod Shipping (GRIN) – Asset Sales Enhance Dry Bulk Exposure – Raising Price Target

Posted on by Admin

Wednesday, March 31, 2021

Grindrod Shipping (GRIN)
Asset Sales Enhance Dry Bulk Exposure – Raising Price Target

Grindrod Shipping, originated in South Africa with roots dating back to 1910. The company is based in Singapore, with offices around the world including, London, Durban, Cape Town, Tokyo and Rotterdam. Its primary listing is on Nasdaq and secondary listing on the JSE.

Grindrod Shipping owns and operates a diversified fleet of owned, long-term chartered and joint-venture dry-bulk and liquid-bulk vessels across the globe.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Added asset sales improve fleet profile and enhance dry bulk market focus. Agreements to sell two MRs and one small tanker for almost $50 million improves the fleet profile and shifts the focus to the dry bulk market. The Leopard Moon and Leopard Sun, two 2013-built MR refined product tankers, will be sold for $42.8 million. In addition, the Breede, a 2009-built small tanker will be sold for $6.8 million. All sales should be completed in 2Q2021. As a result, the fleet will consist of 15 Handysize, 16, Supramax/Ultramax, and one MR tanker that is bareboat charter-out.

    Asset sales reduce financial leverage.  Disciplined capital strategy intact. Proceeds and existing cash will pay off secured debt on the vessels and high cost Sankaty debt of $26 million due in June. The debt maturity profile appears manageable with no added debt maturing in 2021. Capital allocation remains disciplined as evidenced by the decision to shun scrubbers. Buybacks might ramp up once the …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision.